Blueshift Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-973	Closed	-$617K	–	574
2025 Q1	$617K	Sell	973 -330	-25%	-$227K	0.24%	106
2024 Q4	$928K	Buy	1,303 +964	+284%	+$809K	0.34%	65
2024 Q3	$356K	Buy	+339	New	+$377K	0.09%	246
2023 Q3	–	Sell	-1,400	Closed	-$1.01M	–	396
2023 Q2	$1.01M	Buy	+1,400	New	+$1.08M	0.38%	57
2023 Q1	–	Sell	-330	Closed	-$238K	–	440
2022 Q4	$238K	Buy	+330	New	+$243K	0.11%	268
2022 Q1	–	Sell	-793	Closed	-$501K	–	1082
2021 Q4	$501K	Sell	793 -789	-50%	-$485K	0.04%	475
2021 Q3	$957K	Buy	+1,582	New	+$982K	0.05%	417
2021 Q2	–	Sell	-2,282	Closed	-$1.08M	–	1128
2021 Q1	$1.08M	Buy	+2,282	New	+$1.11M	0.11%	255
2020 Q1	–	Sell	-11,019	Closed	-$4.14M	–	581
2019 Q4	$4.14M	Buy	11,019 +9,389	+576%	+$3.16M	0.47%	27
2019 Q3	$452K	Buy	+1,630	New	+$482K	0.07%	398
2019 Q2	–	Sell	-890	Closed	-$365K	–	928
2019 Q1	$365K	Buy	+890	New	+$366K	0.05%	472